Emergencies

Good Pharmacy Practice

Patient Safety

Pharmabridge

pharmabridgecollage

Pharmabridge® is a voluntary initiative aimed at strengthening pharmacy services in low-income and emerging countries. Pharmabridge was established to link individuals and institutions together to actively exchange resources and training in pharmacy practice, pharmaceutical science, pharmaceutical industry and professional pharmacy education.

Supported by the International Pharmaceutical Federation (FIP), Pharmabridge was founded in 1999, to foster communication and exchange of information, resources, and experiences between pharmacists, pharmaceutical scientists, and pharmacy educators from all corners of the globe, leading to better pharmacy services, improved patient care and enhanced community health.

The Pharmabridge project aims to strengthen pharmaceutical services and pharmacy education in developing and transitional countries through coordinated support from pharmacy establishments in developed and more advanced developing countries.
This is accomplished by establishing institutional and personal links between schools of pharmacy, pharmacists associations, drug information centres, hospital pharmacies and individual pharmacists.

Pharmabridge is supported by the FIP Foundation for education and research. If you would like to get involved or donate for this project, please visit the FIP Foundation website here.

See also the Pharmabridge Flyer (here) and an article on Building the global bridge published in the IPJ Vol.22, no 1 June 2007.

FIP Education Initiative – FIPEd

FIPEd, the new umbrella directorate encompassing FIP Education Initiative, is bringing together all of FIP’s education actions; strengthening our projects and our partnerships with the World Health Organization (WHO) and with UNESCO.

 

 

During the congress, the structure and activities of FIPEd were presented during several meetings, including in the FIP Bureau and Council meeting. The FIP Bureau reviewed the first FIPEd Steering Committee Terms of Reference, which outlines the roles and responsibilities of the Steering Committee, staff and appointed volunteer leaders. The appointed Steering Committee members include: the Chair, Dr Henri Manasse, the BPP Representative, Assoc Prof Jennifer Marriott, and the BPS representative, Prof Ross McKinnon.

FIPEd is comprised by the Academic Institutional Membership (AIM), led by Dr Wayne Hindmarsh, Canada; the Pharmacy Education Taskforce, led by Prof Ian Bates, UK; and the Academic Section, Presided by Dr Ralph Altiere, USA.

FIPEd is working to stimulate transformational change in pharmaceutical education and engender the development of science and practice, towards meeting present and future societal and workforce needs around the world.  We are advocating for the use of needs-based strategies where pharmacy education is socially accountable, where practice and science are evidence-based and practitioners have the required competencies to provide the needed services to their communities.

FIP Education Initiative will be achieved through:

  • providing a global platform for exchange, mentoring and learning for leaders and academics, focussing on the development of leadership skills and academic management and pedagogic skills;
  • building, advocating for, and disseminating evidence-based guidance, consensus-based standards, tools and resources for educational development for both organisations and practitioners.

Building on the success of the action plan (2008-2010) implemented by the FIP-WHO-UNESCO Pharmacy Education Taskforce the domains of activity will continue to move forward and to grow sustainably.

For further information about FIPEd and its activities, please contact us by email at education@fip.org.

FIPEd Development Team

FIP AIM

 Academic Pharmacy Section

FIPEd logo

Pictogram Software

How to access the pictogram software:

As downloadable software:

How / When to use pictograms

Pictograms give health professionals a means of communicating medication instructions to people with no common language and / or who may be illiterate. Pictograms may also be used for those who have slight cognitive impairment or difficulties seeing such as the elderly. To help improve communication, various formats of the medication instructions can be printed (see below):

 

Medication instructions included:

  • Medication name
  • Route and quantity of medicines per dose
  • Frequency

 

Optional instructions to include on information sheets:

  • The picture of the medication
  • Reason(s) for use
  • Precautions
  • Side effects (up to 2)

 

More information on

The FIP Challenge on TB – ROUND 1

NEWS!

Will another one million die of tuberculosis next year? FIP’s Mike Spijker spoke to TB workers @FIPcongress in Thailand and found out about the Stop TB Partnership, which is hosted by the World Health Organization. The partnership has been established to help countries access quality assured drugs.

Website: http://www.stoptb.org/

 

 

 

MoU

 

MoU Signing

 

 

 

 

 

The Indian Pharmaceutical Association (IPA) signs MoU with other national bodies to increase pharmacists involvement in the care and control of TB – amonumental step in fighting TB in India. Click here to read the full MoU and click here to read a latest article on  how pharmacists are making a huge impact in the fight against TB in India.

 

Pharmacists can contribute significantly to different tasks essential for quality TB care.

The FIP Challenge – a Request for Proposals (RFP) will be made in the 2011 for national pharmacy professional associations (FIP member organization) and national pharmacy student associations (IPSF member organization) to submit proposals on innovative approaches to target the following interventions:
•    Early identification of TB suspects and referral activities for diagnosis thereby reducing delays in diagnosis, saving costs of care and contributing to increasing case detection.
•    Support delivery of DOTS treatment focusing on training of pharmacists and patient adherence, so as to enhance treatment success, reducing defaults and contributing to cutting the disease transmission.
•    Improving rational use of anti-TB medicines and contributing to preventing emergence of drug resistance.
•    Public education and communication campaigns on TB and MDR-TB awareness

Up to 5 proposals will be funded for national pharmacy professional associations, each of the value between 5000 to 10000 USD.

Up to 5 proposals will be funded for national pharmacy student associations, each of the value between 1000 to 3000 USD.

 

The FIP Challenge Round 1 will be for the period 2011 to 2012. Detailed proposal application forms can be downloaded here (PDF) and here(Word).

Applicants would be expected to describe proposed interventions for funding, while considering, inter alia, technical issues, cost-effectiveness, feasibility, sustainability and impact.

FIP and the Lilly MDR-TB Partnership
FIP SEARPharm Forum has entered into collaborative participation with Eli Lilly MDR-TB Partnership . The understanding between Eli Lilly and SPF was facilitated by FIP. It is a unique public-private collaboration with the support of Lilly MDR TB in partnership with Government, Chemists Association and the Indian Pharmaceutical Association (IPA) in India.

A pilot project (2010 to 2011) has been launched to train pharmacists for the DOTS protocol. For example, case detection & referral, medication management, counseling and overall monitoring of the treatment in selected hotspots of Mumbai and subsequently advocacy campaigns in other cities in 4 to 5 major cities of India.
Potential collaborations can be extended for other countries on scaling up of these forms of public/private mix approaches.

For 2011 to 2012, FIP will intensify its activities in engaging pharmacists and national associations of pharmacists in combating TB/MDR-TB with support from Lilly MDR-TB Partnership. In addition, FIP Member Organisations may gain access to tools and resources developed by other partners such as the World Medical Association, International Council of Nurses and the International Hospital Federation. These materials could be adapted by use by pharmacists where relevant.

More information about the Lilly MDR-TB Partnership click here

Pharmacists in TB control: their current role

Click here to access a background document on pharmacists and TB control

FIP and Advocacy

FIP and WHO Joint Statement
Systematic efforts will be required to enable pharmacists to achieve their full potential in contributing to TB care and control. This may include sensitizing both national TB programs and national pharmaceutical associations on the benefits of working together. Country-specific models of collaboration on the ground may then have to be developed, tried out, documented and scaled up. To this effect, a joint statement from the International Pharmaceutical Federation and WHO would be a first and important global step forward that may help not only in harnessing the role of pharmacist in TB control but also stimulate national and local efforts aimed at full involvement of pharmacists in TB care and control.

A joint FIP WHO working has been established to develop a Reference Paper on the role of the pharmacist in TB care and control. Following this work, a joint Statement between both organizations will be developed and officially launched at the 71st FIP Congress in Hyderabad, India 2011.


WHO Stop TB Partnership

FIP has been formally accepted to be a Partner of the WHO Stop TB Partnership initiative in 2010.

 

WHO World Health Day 2011

The theme for WHD 2011 is antimicrobial resistance (AMR), with specific reference to three of the world’s major infectious killers: HIV/AIDS, tuberculosis, and malaria. Together these diseases account for the deaths of five million people annually.

WHD 2011, with its focus on AMR in these three global diseases, will provide a valuable conduit to ensure that measures that can reduce and prevent the spread of often lethal drug-resistant forms of tuberculosis, malaria and HIV are established and enforced. At the same time, those measures will have a wider significance. Improved and strengthened health systems and policies that prevent AMR can impact on a broader array of diseases that threaten the lives of many millions of people worldwide. Pharmacists play an important role to ensure responsible use of all antibiotics.

Therefore, FIP has been invited to speak at the WHO High Level Panel on World Health Day in WHO with key messages targeting prescribers and dispensers, public and private, including non-governmental organizations to on the appropriate use of antimicrobials against TB, malaria and HIV.

 

Video 2011 FIP Congress Opening Ceremony

Click to view the video shown at the 2011 FIP Congress Opening Ceremony in Hyderabad, India to mark the signing of the joint WHO-FIP Statement on Tuberculosis

2009 Global Pharmacy Workforce Report

2009 Global Pharmacy Workforce Report

Global Network of Pharmacists Against Tobacco

The Global Network of Pharmacists Against Tobacco, established by FIP is a global forum for pharmacists, pharmaceutical students and their professional organizations as well as other individuals or organizations interested in tobacco cessation and tobacco control activities.

The network was officially launched during the World Conference on Tobacco or Health 2003 in Helsinki, Finland. FIP is actively promoting the implementation of the WHO Framework Convention on Tobacco Control both directly and through its national member organizations.

This international network provides a good opportunity to explore other parts of the world, collect information and promote the role of the pharmacists as well as offer a possibility for pharmaceutical organisations and individual pharmacists to exchange their experiences of smoking cessation work in different practice settings.